Chemicals And Materials Industry Reports

Reports > Chemicals And Materials > Selected Report

Global Radiopharmaceutical Market Report 2018

Single User: $2999
Multiple User: $3999
Enterprise User: $5999


Report Summary:

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:
This report focuses on the Radiopharmaceutical in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

The worldwide market for Radiopharmaceutical is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 8120 million US$ in 2023, from 4940 million US$ in 2017, according to a new GIR study.

Market Segment by Manufacturers, this report covers
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other

Market Segment by Applications, can be divided into
Oncology
Cardiology
Other

There are 15 Chapters to deeply display the global Radiopharmaceutical market.
Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Actinium-225
1.2.2 Lutetium-177
1.2.3 Radium-223
1.2.4 Holmium-166
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Business Overview
2.1.2 Radiopharmaceutical Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Radiopharmaceutical Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Mallinckrodt
2.3.1 Business Overview
2.3.2 Radiopharmaceutical Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Nordion
2.4.1 Business Overview
2.4.2 Radiopharmaceutical Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Triad Isotopes
2.5.1 Business Overview
2.5.2 Radiopharmaceutical Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lantheus
2.6.1 Business Overview
2.6.2 Radiopharmaceutical Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 IBA Group
2.7.1 Business Overview
2.7.2 Radiopharmaceutical Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GE Healthcare
2.8.1 Business Overview
2.8.2 Radiopharmaceutical Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 China Isotope & Radiation
2.9.1 Business Overview
2.9.2 Radiopharmaceutical Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Jubilant Pharma
2.10.1 Business Overview
2.10.2 Radiopharmaceutical Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Eli Lilly
2.11.1 Business Overview
2.11.2 Radiopharmaceutical Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Advanced Accelerator Applications
2.12.1 Business Overview
2.12.2 Radiopharmaceutical Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 SIEMENS
2.13.1 Business Overview
2.13.2 Radiopharmaceutical Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Dongcheng
2.14.1 Business Overview
2.14.2 Radiopharmaceutical Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Navidea
2.15.1 Business Overview
2.15.2 Radiopharmaceutical Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Radiopharmaceutical Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceutical Manufacturer Market Share in 2017
3.3.2 Top 6 Radiopharmaceutical Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Radiopharmaceutical Market Analysis by Regions
4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceutical Sales and Market Share by Regions (2013-2018)
4.1.2 Global Radiopharmaceutical Revenue and Market Share by Regions (2013-2018)
4.2 North America Radiopharmaceutical Sales and Growth Rate (2013-2018)
4.3 Europe Radiopharmaceutical Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Radiopharmaceutical Sales and Growth Rate (2013-2018)
4.5 South America Radiopharmaceutical Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Radiopharmaceutical Sales and Growth Rate (2013-2018)
5 North America Radiopharmaceutical by Countries
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Countries
5.1.1 North America Radiopharmaceutical Sales and Market Share by Countries (2013-2018)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Countries (2013-2018)
5.2 United States Radiopharmaceutical Sales and Growth Rate (2013-2018)
5.3 Canada Radiopharmaceutical Sales and Growth Rate (2013-2018)
5.4 Mexico Radiopharmaceutical Sales and Growth Rate (2013-2018)
6 Europe Radiopharmaceutical by Countries
6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries
6.1.1 Europe Radiopharmaceutical Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Radiopharmaceutical Revenue and Market Share by Countries (2013-2018)
6.2 Germany Radiopharmaceutical Sales and Growth Rate (2013-2018)
6.3 UK Radiopharmaceutical Sales and Growth Rate (2013-2018)
6.4 France Radiopharmaceutical Sales and Growth Rate (2013-2018)
6.5 Russia Radiopharmaceutical Sales and Growth Rate (2013-2018)
6.6 Italy Radiopharmaceutical Sales and Growth Rate (2013-2018)
7 Asia-Pacific Radiopharmaceutical by Countries
7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Radiopharmaceutical Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Radiopharmaceutical Revenue and Market Share by Countries (2013-2018)
7.2 China Radiopharmaceutical Sales and Growth Rate (2013-2018)
7.3 Japan Radiopharmaceutical Sales and Growth Rate (2013-2018)
7.4 Korea Radiopharmaceutical Sales and Growth Rate (2013-2018)
7.5 India Radiopharmaceutical Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Radiopharmaceutical Sales and Growth Rate (2013-2018)
8 South America Radiopharmaceutical by Countries
8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Countries
8.1.1 South America Radiopharmaceutical Sales and Market Share by Countries (2013-2018)
8.1.2 South America Radiopharmaceutical Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Radiopharmaceutical Sales and Growth Rate (2013-2018)
8.3 Argentina Radiopharmaceutical Sales and Growth Rate (2013-2018)
8.4 Colombia Radiopharmaceutical Sales and Growth Rate (2013-2018)
9 Middle East and Africa Radiopharmaceutical by Countries
9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Radiopharmaceutical Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Radiopharmaceutical Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2013-2018)
9.3 UAE Radiopharmaceutical Sales and Growth Rate (2013-2018)
9.4 Egypt Radiopharmaceutical Sales and Growth Rate (2013-2018)
9.5 Nigeria Radiopharmaceutical Sales and Growth Rate (2013-2018)
9.6 South Africa Radiopharmaceutical Sales and Growth Rate (2013-2018)
10 Global Radiopharmaceutical Market Segment by Type
10.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Radiopharmaceutical Sales and Market Share by Type (2013-2018)
10.1.2 Global Radiopharmaceutical Revenue and Market Share by Type (2013-2018)
10.2 Actinium-225 Sales Growth and Price
10.2.1 Global Actinium-225 Sales Growth (2013-2018)
10.2.2 Global Actinium-225 Price (2013-2018)
10.3 Lutetium-177 Sales Growth and Price
10.3.1 Global Lutetium-177 Sales Growth (2013-2018)
10.3.2 Global Lutetium-177 Price (2013-2018)
10.4 Radium-223 Sales Growth and Price
10.4.1 Global Radium-223 Sales Growth (2013-2018)
10.4.2 Global Radium-223 Price (2013-2018)
10.5 Holmium-166 Sales Growth and Price
10.5.1 Global Holmium-166 Sales Growth (2013-2018)
10.5.2 Global Holmium-166 Price (2013-2018)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2013-2018)
10.6.2 Global Other Price (2013-2018)
11 Global Radiopharmaceutical Market Segment by Application
11.1 Global Radiopharmaceutical Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Cardiology Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Radiopharmaceutical Market Forecast (2018-2023)
12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2018-2023)
12.2 Radiopharmaceutical Market Forecast by Regions (2018-2023)
12.2.1 North America Radiopharmaceutical Market Forecast (2018-2023)
12.2.2 Europe Radiopharmaceutical Market Forecast (2018-2023)
12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2018-2023)
12.2.4 South America Radiopharmaceutical Market Forecast (2018-2023)
12.2.5 Middle East and Africa Radiopharmaceutical Market Forecast (2018-2023)
12.3 Radiopharmaceutical Market Forecast by Type (2018-2023)
12.3.1 Global Radiopharmaceutical Sales Forecast by Type (2018-2023)
12.3.2 Global Radiopharmaceutical Market Share Forecast by Type (2018-2023)
12.4 Radiopharmaceutical Market Forecast by Application (2018-2023)
12.4.1 Global Radiopharmaceutical Sales Forecast by Application (2018-2023)
12.4.2 Global Radiopharmaceutical Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 40250

Category: 13

Published date: 2018-06-20 19:55:05

Number of Pages: 130

Publisher Name: GIR

Over all Rating: 87 % (Average of Ratings provided by clients)